EAHP Congress: Focus on Safer and Smarter Drug Management

AmberCell komanda EAHP kongrese


Effective medicine management is one of the most important factors in ensuring patient safety and smooth hospital operations. Errors in prescribing, dispensing, or dispensing medicines remain a serious problem in many European healthcare institutions. Therefore, more and more hospitals are choosing automated, data-driven solutions that help reduce the risk of human errors and ensure traceability of medicines from supply to patient.

In March of this year, the 29th Congress of the European Association of Hospital Pharmacists (EAHP) took place, bringing together professionals from the pharmaceutical sector across the continent. One of the main topics is the automation of drug management systems and Closed Loop Medication Management, which allows monitoring every step of the medicine: from the warehouse to the patient’s bed.

The “AmberCell Solutions” team participated in the 29th EAHP Congress, where they engaged with pharmacists from hospitals in the Baltic countries, international partners, and pharmaceutical sector experts. The discussions analyzed the most relevant drug management topics – from closed supply chain principles to automation possibilities in hospitals. The event also presented technologies that help address safety, efficiency, and traceability challenges in the pharmaceutical supply chain.

Operating across all Baltic countries, “AmberCell Solutions” aims to ensure that hospitals have access to advanced solutions covering the entire drug supply process – from robotic dispensing, smart storage, and automatic replenishment to integration with hospital systems and drug approval at the patient’s bedside.

These solutions help reduce the risk of human error, optimize workflow, reduce staff workload, and ensure data accuracy. They also allow for more efficient use of medicines and more rational resource management.

With the growing need to automate pharmaceutical processes, “AmberCell Solutions” remains a reliable partner for hospitals aiming to implement smart, data-driven solutions throughout the entire pharmaceutical supply chain.

Share:

Related posts

First pulmonary cryoablation at Tartu University Hospital

The first pulmonary cryoablation procedure was successfully performed at Tartu University Hospital. This move strengthens the development of interventional oncology services in the region and provides more minimally invasive treatment options for patients with lung tumors.

Minimally Invasive Liver Cancer Treatment in Klaipeda

At Klaipėda University Hospital, a 70-year-old liver cancer patient who could not undergo surgery was given a minimally invasive treatment method – microwave ablation. During the procedure, the tumor is destroyed by precise exposure to heat, without damaging the surrounding tissues, and the patient’s recovery is faster and easier than after open surgery.